Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00667342 · OUTCOME

2-Year Event Free Survival (EFS) of Patients With Osteosarcoma

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · Source last updated 2023-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
probability
Interval / dispersion
95% Confidence Interval
Time frame
After all patients have completed therapy, up to 2 years after last patient is enrolled

What was measured

Kaplan-Meier method was used to estimate the EFS of patients with osteosarcoma treated with chemotherapy and Bevacizumab.

Analysis population: All the 42 evaluable participants were included in this analysis.

Groups in this outcome

All Participants

All the 42 evaluable participants in this study had osteosarcoma, of which 22 had events and 20 had no event.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Participants42

Reported measurements

Source class 1
Values in probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Participants0.617Not reported0.4700.764Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.470
        upper Limit
        0.764
        value
        0.617
denoms
  1. counts
    1. group Id
      OG000
      value
      42
    units
    Participants
description
Kaplan-Meier method was used to estimate the EFS of patients with osteosarcoma treated with chemotherapy and Bevacizumab.
dispersion Type
95% Confidence Interval
groups
  1. description
    All the 42 evaluable participants in this study had osteosarcoma, of which 22 had events and 20 had no event.
    id
    OG000
    title
    All Participants
param Type
NUMBER
population Description
All the 42 evaluable participants were included in this analysis.
reporting Status
POSTED
time Frame
After all patients have completed therapy, up to 2 years after last patient is enrolled
title
2-Year Event Free Survival (EFS) of Patients With Osteosarcoma
type
SECONDARY
unit Of Measure
probability

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice